Satiety
    2.
    发明授权
    Satiety 有权

    公开(公告)号:US09233075B2

    公开(公告)日:2016-01-12

    申请号:US11990211

    申请日:2006-08-09

    CPC classification number: A61K9/4808 A61F5/0036

    Abstract: A capsule for suppressing appetite, comprising: a) a shell which dissolves in the stomach; and b) a plurality of elements inside the shell, which elements expand inside the stomach, after the shell dissolves, to form a connected mass with an envelope volume greater than the total volume of the elements, and at least 3 times the volume of the capsule.

    Method of treating a patient
    4.
    发明授权
    Method of treating a patient 有权
    治疗病人的方法

    公开(公告)号:US08738127B1

    公开(公告)日:2014-05-27

    申请号:US13450798

    申请日:2012-04-19

    Abstract: There is provided in accordance with an exemplary embodiment of the invention a method of treating diabetic patients comprising measuring a triglyceride level in a diabetic patient and applying a diabetes treatment according to the triglyceride level. Optionally, there is provided a method of screening. Alternatively or additionally, there is provided a method of weight loss. Alternatively or additionally, there is provided a method of relatively reducing HOMA-IR levels. Alternatively or additionally, there is provided a method of relatively reducing blood pressure. An exemplary device to apply the treatment is described.

    Abstract translation: 根据本发明的示例性实施方案,提供治疗糖尿病患者的方法,包括测量糖尿病患者的甘油三酯水平,并根据甘油三酯水平应用糖尿病治疗。 可选地,提供了一种筛选方法。 或者或另外,提供了减肥的方法。 或者或另外,提供了相对减少HOMA-IR水平的方法。 或者或另外,提供了一种相对降低血压的方法。 描述了应用该处理的示例性装置。

    Implantable lead connector
    5.
    发明授权
    Implantable lead connector 有权
    可植入导线连接器

    公开(公告)号:US08706230B2

    公开(公告)日:2014-04-22

    申请号:US13265874

    申请日:2010-04-23

    Abstract: An implantable lead connector configured for long term implantation and to electrically interconnect multiple medical devices and to channel electrical signals between said interconnected devices and a target organ, comprising: a first port adapted to receive a first signal suitable to stimulate a target tissue, a second port adapted to receive a second signal suitable to stimulate a target tissue, and a third port configured to connect to a target organ, wherein at least one of said first and second ports is configured to connect to a signal generator not integrated with said connector.

    Abstract translation: 一种可植入引线连接器,其被配置为长期植入并且电连接多个医疗装置并且在所述互连装置与目标器官之间引导电信号,包括:第一端口,适于接收适于刺激靶组织的第一信号;第二端 适于接收适合于刺激目标组织的第二信号的端口以及被配置为连接到目标器官的第三端口,其中所述第一和第二端口中的至少一个被配置为连接到未与所述连接器集成的信号发生器。

    RADIOIMAGING METHODS USING TEBOROXIME AND THALLIUM
    6.
    发明申请
    RADIOIMAGING METHODS USING TEBOROXIME AND THALLIUM 有权
    使用TEBOROXIME和THALIUM的放射性方法

    公开(公告)号:US20140037541A1

    公开(公告)日:2014-02-06

    申请号:US13913804

    申请日:2013-06-10

    Abstract: A method for imaging is providing, including administering a teboroxime species to an adult human subject, administering T1-201-thallous chloride to the subject performing a teboroxime species SPECT imaging procedure of the teboroxime species on a region of interest (ROI) of the subject, and, after administering the teboroxime species, performing a T1-201-thallous chloride SPECT imaging procedure of the T1-201-thallous chloride on the ROI. Administering the teboroxime species and the T1-201-thallous chloride and performing the teboroxime species and the T1-201-thallous chloride SPECT imaging procedures comprise administering the teboroxime species and the T1-201-thallous chloride and performing the teboroxime species and the T1-201-thallous chloride SPECT imaging procedures during a time period having a duration of no more than 30 minutes. Other embodiments are also described.

    Abstract translation: 用于成像的方法是提供包括向成年人受试者施用脱硼肟物种,向受试者施用T1-201-二氧化氯,所述受试者在所述受试者的感兴趣区域(ROI)上进行茶树癣物种的柚子肟物种SPECT成像程序 ,并且在施用脱烷基咔唑物质后,在ROI上进行T1-201-铊氯化物的T1-201-铊氯化物SPECT成像程序。 管理茶园ime ime ime ime ime ime us 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 1- 201-thallous chloride SPECT成像程序在持续时间不超过30分钟的时间段内。 还描述了其它实施例。

Patent Agency Ranking